After endocrine therapy for postmenopausal early breast cancer, allocation to aromatase inhibitors reduced recurrence at 10 y.
Where this comes from
- Record sourced from PubMed, PMID 41183342.
- Also identified by DOI 10.7326/ANNALS-25-04293-JC.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
GIM/FP/GP: [Formula: see text].
Medical subject headings
- Aromatase Inhibitors
- Breast Neoplasms
- Neoplasm Recurrence, Local
- Antineoplastic Agents, Hormonal